LLP-3 |
Katalog-Nr.GC44080 |
LLP-3 ist ein potenter Survivin-Inhibitor, der die Survivin-Ran-Interaktion in Krebszellen unterbricht. LLP-3 kann bei der Erforschung von Glioblastoma multiforme (GBM) verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1453835-43-2
Sample solution is provided at 25 µL, 10mM.
Survivin (also known as baculoviral IAP repeat-containing protein 5 (BIRC5)) is a member of the inhibitor of apoptosis (IAP) family that interacts with and inhibits the apoptotic function of several proteins. LLP-3 is a cell-permeable ligand of Survivin that blocks its interaction with Ran, resulting in the induction of apoptosis (IAP) in glioma stem cells (IC50 = 31 µM). It abolishes the growth of glioblastoma multiforme cell in spheres and in tumor slice cultures.
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *